Corteva (NYSE:CTVA) Releases FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) updated its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.760-0.800 for the period, compared to the consensus EPS estimate of 1.070.

Corteva Stock Performance

Shares of CTVA stock opened at $9.26 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a fifty day moving average price of $38.81 and a two-hundred day moving average price of $69.88. The stock has a market cap of $6.18 billion, a P/E ratio of 6.13, a P/E/G ratio of 1.69 and a beta of 0.58. Corteva has a one year low of $9.14 and a one year high of $90.97.

Corteva Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be paid a $0.05 dividend. This is a negative change from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, December 1st. Corteva’s dividend payout ratio is currently 47.68%.

Analyst Ratings Changes

Several equities research analysts have issued reports on CTVA shares. Mizuho set a $16.00 price target on Corteva in a report on Thursday. Citigroup increased their price objective on shares of Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research report on Thursday, September 17th. Royal Bank Of Canada reissued an “outperform” rating and issued a $17.00 price objective on shares of Corteva in a research report on Wednesday, October 7th. New Street Research set a $17.00 target price on shares of Corteva in a research note on Monday, October 5th. Finally, Argus restated a “buy” rating and set a $91.00 price objective on shares of Corteva in a report on Friday, September 18th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $56.91.

More Corteva News

Investors following CTVA have been watching these news items:

• Positive Sentiment: Corteva reported third-quarter adjusted EPS of $0.06, above the $0.02 analyst consensus, and said growth in new-product sales and operational execution helped offset market headwinds. Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook
• Negative Sentiment: Quarterly sales fell 8.7% year over year, and reports described the results as weaker than expected overall. The CEO warned that Brazil’s slump is likely to persist, raising concerns about continued pressure on results. Corteva shares plunge as CEO warns Brazil slump will drag on
• Negative Sentiment: A law firm announced an investigation into possible securities-law violations related to Corteva. The announcement adds a potential legal overhang but is an investigation, not a finding of wrongdoing. Law firm announces investigation into Corteva

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.